Manipulation of host innate immune responses by the malaria parasite

Trends in Microbiology

Volumn 15, Issue 6, 2007, Pages 271-278

  Coban, Cevayir ^a   Ishii, Ken J ^a,b   Horii, Toshihiro ^a   Akira, Shizuo ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ANEMIA; BRAIN MALARIA; CYTOKINE RELEASE; DISEASE SEVERITY; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INNATE IMMUNITY; LIVER; LIVER DISEASE; LOW BIRTH WEIGHT; MALARIA; NONHUMAN; PARASITE DEVELOPMENT; PATHOGENESIS; PLASMODIUM; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; SPOROZOITE;

ANIMALS; HUMANS; IMMUNITY, NATURAL; MALARIA; PLASMODIUM; POLYMORPHISM, GENETIC; SPOROZOITES; TOLL-LIKE RECEPTORS;

MUS;

EID: 34249808490     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2007.04.003     Document Type: Review

References (79)

1. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
2. Akira S., et al. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
3. Beutler B., et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24 (2006) 353-389
4. Creagh E.M., and O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27 (2006) 352-357
5. Meylan E., et al. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
6. Singh B., et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 363 (2004) 1017-1024
7. Hisaeda H., et al. Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells. Nat. Med. 10 (2004) 29-30
8. Riley E.M., et al. Regulating immunity to malaria. Parasite Immunol. 28 (2006) 35-49
9. Good M.F. Identification of early cellular immune factors regulating growth of malaria parasites in humans. Immunity 23 (2005) 241-242
10. Engwerda C.R., and Good M.F. Interactions between malaria parasites and the host immune system. Curr. Opin. Immunol. 17 (2005) 381-387
11. Gazzinelli R.T., and Denkers E.Y. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat. Rev. Immunol. 6 (2006) 895-906
12. Bull P.C., et al. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4 (1998) 358-360
13. Hviid L. Naturally acquired immunity to Plasmodium falciparum malaria in Africa. Acta Trop. 95 (2005) 270-275
14. Adachi K., et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and Toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 167 (2001) 5928-5934
15. Krishnegowda G., et al. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280 (2005) 8606-8616
16. Coban C., et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201 (2005) 19-25
17. Pichyangkul S., et al. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J. Immunol. 172 (2004) 4926-4933
18. Campos M.A., et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167 (2001) 416-423
19. Schofield L., et al. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418 (2002) 785-789
20. Coban C., et al. Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Infect. Immun. 70 (2002) 3939-3943
21. Deshpande P., and Shastry P. Modulation of cytokine profiles by malaria pigment-hemozoin: role of IL-10 in suppression of proliferative responses of mitogen stimulated human PBMC. Cytokine 28 (2004) 205-213
22. Jaramillo M., et al. Hemozoin-inducible proinflammatory events in vivo: potential role in malaria infection. J. Immunol. 172 (2004) 3101-3110
23. Prato M., et al. Phagocytosis of hemozoin enhances matrix metalloproteinase-9 activity and TNF-α production in human monocytes: role of matrix metalloproteinases in the pathogenesis of falciparum malaria. J. Immunol. 175 (2005) 6436-6442
24. Nti B.K., et al. Stage-specific effects of Plasmodium falciparum-derived hemozoin on blood mononuclear cell TNF-α regulation and viral replication. AIDS 19 (2005) 1771-1780
25. Huy N.T., et al. Leukocyte activation by malarial pigment. Parasitol. Int. 55 (2006) 75-81
26. Jaramillo M., et al. Hemozoin induces macrophage chemokine expression through oxidative stress-dependent and -independent mechanisms. J. Immunol. 174 (2005) 475-484
27. Keller C.C., et al. Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia. Infect. Immun. 74 (2006) 5249-5260
28. Awandare G.A., et al. Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect.Immun. 75 (2007) 201-210
29. McDevitt M.A., et al. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J. Exp. Med. 203 (2006) 1185-1196
30. Millington O.R., et al. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J. Biol. 5 (2006) 5
31. Perry J.A., et al. Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J. Immunol. 174 (2005) 5921-5925
32. Ing R., et al. Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J. Immunol. 176 (2006) 441-450
33. Wilson N.S., et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7 (2006) 165-172
34. Parroche P., et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 1919-1924
35. Marshak-Rothstein A., et al. Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells. J. Endotoxin Res. 10 (2004) 247-251
36. Coban C., et al. Pathological role of Toll-like receptor signaling in cerebral malaria. Int. Immunol. 19 (2006) 67-79
37. Yarovinsky F., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308 (2005) 1626-1629
38. Ndungu F.M., et al. Regulation of immune response by Plasmodium-infected red blood cells. Parasite Immunol. 27 (2005) 373-384
39. Roetynck S., et al. Natural killer cells and malaria. Immunol. Rev. 214 (2006) 251-263
40. Baratin M., et al. Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A 102 (2005) 14747-14752
41. Ockenhouse C.F., et al. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect. Immun. 74 (2006) 5561-5573
42. Walther M., et al. Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J. Immunol. 177 (2006) 5736-5745
43. Demeure C.E., et al. Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J. Immunol. 174 (2005) 3932-3940
44. Lu Z., et al. Disruption of JNK2 decreases the cytokine response to Plasmodium falciparum glycosylphosphatidylinositol in vitro and confers protection in a cerebral malaria model. J. Immunol. 177 (2006) 6344-6352
45. Gramzinski R.A., et al. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect. Immun. 69 (2001) 1643-1649
46. Jones T.R., et al. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine 17 (1999) 3065-3071
47. Su Z., et al. Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice. Infect. Immun. 71 (2003) 5178-5187
48. Coban C., et al. Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen. Infect. Immun. 72 (2004) 584-588
49. Kumar S., et al. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine. Infect. Immun. 72 (2004) 949-957
50. Rosa D.S., et al. Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus). Microbes Infect. 8 (2006) 2130-2137
51. Mullen G.E., et al. Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide. Vaccine 24 (2006) 2497-2505
52. Cook D.N., et al. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5 (2004) 975-979
53. Turvey S.E., and Hawn T.R. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin. Immunol. 120 (2006) 1-9
54. Schroder N.W., and Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5 (2005) 156-164
55. Mockenhaupt F.P., et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 177-182
56. Mockenhaupt F.P., et al. Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J. Infect. Dis. 194 (2006) 184-188
57. Khor C.C., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet. 39 (2007) 523-528
58. Aitman T.J., et al. Malaria susceptibility and CD36 mutation. Nature 405 (2000) 1015-1016
59. Hoebe K., et al. CD36 is a sensor of diacylglycerides. Nature 433 (2005) 523-527
60. Nussenzweig V., and Nussenzweig R.S. Circumsporozoite proteins of malaria parasites. Cell 42 (1985) 401-403
61. Miller L.H., et al. Research toward malaria vaccines. Science 234 (1986) 1349-1356
62. Hoffman S.L., et al. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat. Med. 3 (1997) 80-83
63. Klinman D.M., et al. Immune recognition of foreign DNA: a cure for bioterrorism?. Immunity 11 (1999) 123-129
64. Amino R., et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 12 (2006) 220-224
65. Kumar K.A., et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444 (2006) 937-940
66. Frevert U., et al. Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol. 3 (2005) e192
67. Baer K., et al. Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver. Cell Microbiol. 9 (2007) 397-412
68. Steers N., et al. The immune status of Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites. Eur. J. Immunol. 35 (2005) 2335-2346
69. Sturm A., et al. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313 (2006) 1287-1290
70. Leiriao P., et al. Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells. J. Infect. Dis. 191 (2005) 1576-1581
71. Silvie O., et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat. Med. 9 (2003) 93-96
72. Silvie O., et al. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. Cell. Microbiol. 8 (2006) 1134-1146
73. Miyazaki T., et al. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J. 16 (1997) 4217-4225
74. Mueller A.K., et al. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3022-3027
75. Mueller A.K., et al. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433 (2005) 164-167
76. van Dijk M.R., et al. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12194-12199
77. Ishino T., et al. Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte. Mol. Microbiol. 58 (2005) 1264-1275
78. Good M.F. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies. Trends Immunol. 26 (2005) 295-297
79. Mikolajczak S.A., and Kappe S.H. A clash to conquer: the malaria parasite liver infection. Mol. Microbiol. 62 (2006) 1499-1506